Improving thyroid cancer diagnosis using advanced AI technology
Official title: Advancing Thyroid Cancer Diagnostics with AI-enhanced Multimodal Optical Histopathology
Funded at Methodist Hospital Research Institute · NIH-11047378 · Data updated 2026-11-12
This study is working on a new way to help doctors better diagnose thyroid cancer using advanced imaging technology, which could lead to more accurate results and fewer unnecessary procedures for patients with thyroid nodules.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Methodist Hospital Research Institute NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | January 1, 2025 |
| Project end | December 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $593,383 |
| NIH project number | 1R01CA288613-01A1 |
| Project ID | NIH-11047378 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults aged 21 and older who have thyroid nodules that require diagnostic evaluation.
✕Less likely to help
Patients with confirmed thyroid cancer or those who do not have thyroid nodules may not benefit from this research.
What this research studies
This research aims to enhance the accuracy of thyroid cancer diagnostics by developing an AI-augmented multimodal optical microscopy system. It addresses the challenges of current diagnostic methods, such as fine needle aspiration and core needle biopsies, which often yield indeterminate results and can lead to unnecessary procedures. By utilizing advanced imaging techniques, the study seeks to provide clearer, more reliable diagnostic information, potentially reducing the need for repeat biopsies and improving patient outcomes. The approach focuses on minimizing sampling errors and enhancing the detection of malignancies in thyroid nodules.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and less invasive diagnostic methods for thyroid cancer, improving patient care and reducing healthcare costs.
How similar studies have gone: Other research has shown promise in using AI and advanced imaging techniques for cancer diagnostics, indicating a potential for success in this novel approach.
Where this research is happening
-
Methodist Hospital Research Institute
Houston, United States Active
Researchers
- Principal investigator: Wong, Stephen Tc — Methodist Hospital Research Institute
- Study coordinator: Wong, Stephen Tc
Related research
Other NIH-funded projects on the same topics.
-
WTC Dust and Thyroid Cancer Progression in Human Organoids
This grant tests how World Trade Center dust might influence thyroid cancer progression using human thyroid organoids to model real-life exposure.
-
Integrating molecular signals to guide thyroid cancer care
A doctor-scientist team at Brigham and Women’s Hospital is studying how tumor biology and the immune environment can guide personalized monitoring and treatment for differentiated thyroid cancer.
-
Metabolic Imaging to Track Treatment Response in Aggressive Thyroid Cancer
This grant explores a new way to watch how aggressive thyroid cancers respond to treatment using a special MRI technique that tracks tumor metabolism.
-
Adoptive T-cell Therapy for Anaplastic Thyroid Cancer
A patient-focused program explores using patient immune cells engineered to target and fight anaplastic thyroid cancer, especially for those whose cancer has stopped responding to standard treatments.
-
Overcoming Resistance to BRAF Inhibitors in Aggressive Thyroid Cancers
A patient-focused research effort to find new ways to treat difficult thyroid cancers that no longer respond to current BRAF inhibitors.
-
Improving Treatment of Anaplastic Thyroid Cancer with New Therapies and Early Response Checks
This NIH grant aims to advance treatment for a rare, aggressive thyroid cancer by testing new approaches and measuring how tumors respond early in treatment to tailor care.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.